Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirapazamine TATE vs TACE in Hepatocellular Carcinoma (China, Phase I/II)
CTR20210270Phase 2Terminated
- Sponsor
- Teclison
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirapazamine in hepatocellular carcinoma (HCC), sponsored by Teclison. Started Feb 2021; status: terminated.
02
Drugs
tirapazamine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20210270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210270.